Light-activated compound offers hope for overcoming drug resistance in cancer treatment
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...
Inhibiting a gene provides a new weapon to fight treatment-resistant melanoma
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Active agent against cancer metastasis discovered: Adhibin prevents migration and attachment to other cells
Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...
The Lancet22h
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...